About Infallible Pharma
Infallible Pharma is a Healthcare company based in India founded in 2005 by Hari Om. RD company manufacturing drugs for multiple therapeutic areas. Infallible Pharma has raised $403.65 thousand across 1 funding round from investors including Bharat Shah and Anuradha Bharat Shah. The company has 69 employees. Infallible Pharma was last valued at $4.04 million in November 2021. Its chief executive, as recorded, is Hari Om. Its Indian entity Infallible Pharma Private Limited reported revenue of ₹107 Cr. Infallible Pharma offers products and services including Inflorin, IParin, Infamero, and Xzone. Its focus areas include Diversified Pharmaceuticals.
Company details
Infallible Pharma, backed by 403650.0 from Bharat Shah, Anuradha Bharat Shah, focuses on providing healthcare solutions, and diversified pharmaceuticals. RD company manufacturing drugs for multiple therapeutic areas. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters India
- Employees 69
- Founders Hari Om
- Stage Minicorn
- SectorsHealthcare
- Website infalliblepharma.com
- Legal Name Infallible Pharma Private Limited
- Date of Incorporation 20 Mar, 2019
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹107 Cr
FY 2025 · +3% YoY
- Net Profit₹10.7 Lakh
FY 2025 · 0% margin
- EBITDA₹3.37 Cr
FY 2025 · 3% margin
- Total Equity Funding$403.65K (USD)
in 1 rounds
- Latest Funding Round$403.65K (USD), Angel Round
Nov 2021
- Employee Count69
Associated legal entities of Infallible Pharma
Infallible Pharma operates through Infallible Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Infallible Pharma Private Limited CIN U24304MH2019PTC322834 | Active | 20 Mar 2019 | Mumbai, Maharashtra | ₹107 Cr | 69 | 3 | View details |
Products & Services of Infallible Pharma
Infallible Pharma offers a comprehensive portfolio of products and services, including Inflorin, IParin, Infamero, and Xzone.
Anticoagulant drug for critical care in hospitals.
Anticoagulant product for medical and hospital use.
Antibiotic for treating infections in critical settings.
Antibiotic drug used in hospital critical care.
Funding Insights of Infallible Pharma
Infallible Pharma has successfully raised a total of $403.65K through 1 strategic funding round. The most recent funding activity was a Angel Round of $403.65 thousand completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $403,650
- Total Rounds 1
- Last Round Angel Round — $403,650
- First Round $403,650
(Nov 2021)
- Investors Count 2
All 1 funding rounds of Infallible Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2021 | $403,650 | Angel Round | $4.04M | Bharat Shah |
| Date | Valuation | Stage |
|---|---|---|
| Nov 2021 | $4.04M | •••••••• |
Last known valuation $4.04M (Nov 2021). 2 investors in total: 0 institutional and 2 angel.
Investors in Infallible Pharma
Infallible Pharma has secured backing from 2 investors, including angel investors. Prominent investors backing the company include Bharat Shah and Anuradha Bharat Shah.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
BS Bharat Shah | unknown_fefd69bfa44d43a4b | |||
AB Anuradha Bharat Shah | unknown_a66aacb6edc142219 |
Investor details for Infallible Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Infallible Pharma Private Limited (Infallible Pharma)
Infallible Pharma Private Limited is the primary company behind Infallible Pharma. The board of Infallible Pharma Private Limited currently have 3 directors; the longest-serving is Hari Om, appointed in 2019. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Hari Om DIN 07990559 | Managing Director | 20 Mar 2019 | 7 yrs 7 mo | Infallible Pharma Private Limited |
| Shreekant Krishna Shetty DIN 05317103 | Whole-time director | 01 Sep 2019 | 7 yrs 2 mo | Infallible Pharma Private Limited |
| Hari Krishnababu Naidu DIN 10871920 | Director | 16 Dec 2024 | 1 yr 10 mo | Infallible Pharma Private Limited |
People of Infallible Pharma
1 people are tracked at Infallible Pharma (1 in leadership); the tracked headcount is 69.
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership |
Complete people profiles for Infallible Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Infallible Pharma
Figures of Infallible Pharma Private Limited, the primary company behind Infallible Pharma, for FY 2025. Revenue was ₹107 Cr (+3% year on year). Net profit was ₹10.7 Lakh (0% margin). EBITDA was ₹3.37 Cr (3% margin). Revenue has grown at a compounded annual rate of -9% over three years and +111% over five years.
- ₹107 CrRevenue · FY 2025 · +3% YoY
- ₹10.7 LakhNet profit · 0% margin
- ₹3.37 CrEBITDA · 3% margin
- ₹2.44 CrPaid-up capital
- 69Employees (provident fund records)
- -9%Revenue CAGR, 3 years
- +111%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Infallible Pharma Private Limited are on its company page.
Detailed financial statements for Infallible Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Infallible Pharma
3 dated milestones of Infallible Pharma across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Infallible Pharma is founded.
- Funding First funding round of $404K.
- Milestone Reaches Minicorn status.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Infallible Pharma
Complete news archive for Infallible Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Infallible Pharma
Infallible Pharma was founded in 2005 and raised its 1st funding round 16 years after it was founded.
Infallible Pharma is headquartered in India.
Hari Om is the CEO of Infallible Pharma, as recorded in our data. They have also founded this company.
Infallible Pharma is a funded company, having raised a total of $403.65K across 1 funding round to date. The company's 1st funding round was a Angel Round of $403.65K, raised on Nov 2021.
Infallible Pharma has 69 employees.
The primary company behind Infallible Pharma, Infallible Pharma Private Limited, reported revenue of ₹107 Cr for FY 2025, up 3% year on year.
Infallible Pharma, backed by 403650.0 from Bharat Shah, Anuradha Bharat Shah, focuses on providing healthcare solutions, and diversified pharmaceuticals. RD company manufacturing drugs for multiple therapeutic areas. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
Infallible Pharma offers Inflorin, IParin, Infamero, and Xzone.
Infallible Pharma has 2 investors. Key investors include Bharat Shah, and Anuradha Bharat Shah.
The valuation of Infallible Pharma is $4.04M as of Nov 2021.
Infallible Pharma operates through Infallible Pharma Private Limited.
The legal entities of Infallible Pharma currently have 3 directors, including Shreekant Krishna Shetty, Hari Om, Hari Krishnababu Naidu.